Increased Prevalence of Subcutaneous Lipomas in Patients with Wilson Disease

Journal of Clinical Gastroenterology

Volumn 49, Issue 7, 2015, Pages e61-e63

  Schaefer, Mark ^a   Gotthardt, Daniel N ^a   Didion, Christian ^a   Stremmel, Wolfgang ^a   Weiss, Karl H ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

ATP7B; copper; lipoma; Wilson's disease

Indexed keywords

CHELATING AGENT; PENICILLAMINE; TRIENTINE; ZINC; COPPER; TRACE ELEMENT;

ABDOMEN; ADULT; ARM; ARTICLE; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; GENOTYPE; HEAD; HUMAN; LEG; LIPOMA; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; SKIN TUMOR; SUBCUTANEOUS LIPOMA; TERTIARY CARE CENTER; THORAX; WILSON DISEASE; COMPLICATION; CONNECTIVE TISSUE DISEASE; HEPATOLENTICULAR DEGENERATION; MIDDLE AGED; NEOPLASMS, CONNECTIVE TISSUE; PATHOLOGY; SUBCUTANEOUS TISSUE;

ADULT; CONNECTIVE TISSUE DISEASES; COPPER; DISEASE PROGRESSION; FEMALE; HEPATOLENTICULAR DEGENERATION; HUMANS; LIPOMA; MALE; MIDDLE AGED; NEOPLASMS, CONNECTIVE TISSUE; PREVALENCE; SUBCUTANEOUS TISSUE; TRACE ELEMENTS;

EID: 84937711841     PISSN: 01920790     EISSN: 15392031     Source Type: Journal    
DOI: 10.1097/MCG.0000000000000248     Document Type: Article

References (22)

1. Rosencrantz R, Schilsky M. Wilson disease: pathogenesis and clinical considerations in diagnosis and treatment. Semin Liver Dis. 2011;31:245-259.
2. Ala A, Walker AP, Ashkan K, et al. Wilson's disease. Lancet. 2007;369:397-408.
3. Weiss KH, Stremmel W. Evolving perspectives in Wilson disease: diagnosis, treatment and monitoring. Curr Gastroenterol Rep. 2012;14:1-7.
4. Roberts EA, Schilsky ML. AASL practice guidelines: diagnosis and treatment of Wilson disease. Hepatology. 2008;47:2089-2111.
5. Ferenci P, Czlonkowska A, Stremmel W, et al. EASL clinical practice guidelines:Wilson's disease. J Hepatol. 2012;56:671-685.
6. Schaefer M, Schellenberg M, Merle U, et al. Wilson protein expression, copper excretion and sweat production in sweat glands of Wilson disease patients and control. BMC Gastroenterol. 2008;8:29.
7. Weiss KH, Wurz J, Gotthardt D, et al. Localization of the Wilson disease protein in murine intestine. J Anat. 2008;213:232-240.
8. Barnes N, Bartee MY, Braiterman L, et al. Cell-specific trafficking suggests a new role for renal ATP7B in the intracellular copper storage. Traffic. 2009;10:767-779.
9. Leu ML, Strickland GT, Wang CC, et al. Skin pigmentation in Wilson's disease. JAMA. 1970;211:1542-1543.
10. Seyhan M, Erdem T, Selimoglu MA, et al. Dermatological signs in Wilson's disease. Pediatr Int. 2009;51:395-398.
11. Thaipisuttikul Y. Acanthosis nigricans associated with hepatolenticular degeneration. J Dermatol. 1997;24:295-400.
12. Rath N, Bhardwaj A, Kar HK, et al. Penicillamine induced pseudoxanthoma elasticum with elastosis perforans serpiginosa. Indian J Dermatol Venereol Leprol. 2005;71:182-185.
13. Hill VA, Seymour CA, Mortimer PS. Penicillamine-induced elastosis perforans serpiginosa and cutis laxa in Wilson's disease. Br J Dermatol. 2000;142:560-561.
14. Iozumi K, Nakagawa H, Tamaki K. Penicillamine-induced degenerative dermatoses: a report of a case and brief review of such dermatoses. J Dermatol. 1997;24:458-465.
15. James W, Berger T, Elston D. Andrews' Diseases of the Skin: Clinical Dermatology. 10th ed. Philadelphia, PA: Saunders; 2005.
16. Weiss SW. Lipomatous tumors. Monogr Pathol. 1996;38: 207-339.
17. Weiss KH, Gotthardt DN, Klemm D, et al. Zinc monotherapy is not as effective as chelating agents in treatment of Wilson Disease. Gastroenterology. 2011;140:1189-1198, e1.
18. Weiss KH, Thurik F, Gotthardt DN, et al. Efficacy and safety of oral chelators in treatment of patients with Wilson disease. Clin Gastroenterol Hepatol. 2013;11:1028-1035, e1-2.
19. Bartuma H, Hallor KH, Panagopoulos I, et al. Assessment of the clinical and molecular impact of different cytogenetic subgroups in a series of 272 lipomas with abnormal karyotype. Genes Chromosomes Cancer. 2007;46:594-606.
20. Dahlén A, Debiec-Rychter M, Pedeutour F, et al. Clustering of deletions on chromosome 13 in benign and low malignant lipomatous tumors. Int J Cancer. 2003;103:616-623.
21. Pedeutour F, Foa C. From cytogenetics to cytogenomics of adipose tissue tumors: Benign adipose tissue tumors [In French]. Bull Cancer. 2002;89(7-8):689-695.
22. Bartuma H, Nord KH, Macchia G, et al. Gene expression and single nucleotide polymorphism array analysis of spindle cell lipomas and conventional lipomas with 13q14 deletions. Genes Chromosomes Cancer. 2011;50:619-632.